Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
3 Visninger
• 08/04/23
0
0
Indlejre
administrator
Abonnenter
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer